T. Rowe Price Associates’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $229K | Buy |
|
|||||
|
2025
Q1 | $210K | Buy |
|
|||||
|
2024
Q4 | $245K | Buy |
|
|||||
|
2024
Q3 | $464K | Buy |
|
|||||
|
2024
Q2 | $475K | Buy |
|
|||||
|
2024
Q1 | $430K | Buy |
|
|||||
|
2023
Q4 | $248K | Sell |
|
|||||
|
2023
Q3 | $318K | Buy |
|
|||||
|
2023
Q2 | $258K | Buy |
|
|||||
|
2023
Q1 | $291K | Buy |
|
|||||
|
2022
Q4 | $283K | Sell |
|
|||||
|
2022
Q3 | $366K | Sell |
|
|||||
|
2022
Q2 | $693K | Buy |
|
|||||
|
2022
Q1 | $601K | Buy |
|
|||||
|
2021
Q4 | $309K | Sell |
|
|||||
|
2021
Q3 | $737K | Buy |
|
|||||
|
2021
Q2 | $688K | Buy |
|
|||||
|
2021
Q1 | $897K | Buy |
|
|||||
|
2020
Q4 | $778K | Buy |
|
|||||
|
2020
Q3 | $640K | Buy |
|